|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 217/00 | |
| C07D 401/12 | |||
| C07D 409/12 | |||
| C07D 417/12 | |||
| C07C 237/00 | |||
| A61P 27/00 | |||
| A61K 31/33 |
| (11) | Number of the document | 2424842 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10709100.1 |
| Date of filing the European patent application | 2010-01-27 | |
| (97) | Date of publication of the European application | 2012-03-07 |
| (45) | Date of publication and mention of the grant of the patent | 2015-10-28 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2010/022246 |
| Date | 2010-01-27 |
| (87) | Number | WO 2010/126626 |
| Date | 2010-11-04 |
| (30) | Number | Date | Country code |
| 174672 P | 2009-05-01 | US |
| (72) |
DELONG, Mitchell, A., US
STURDIVANT, Jill, Marie, US
ROYALTY, Susan, M., US
|
| (73) |
Aerie Pharmaceuticals, Inc.,
7020 Kit Creek Road, Suite 270 P. O. box 12320, Research Triangle Park, NC 27709,
US
|
| (54) | DUAL MECHANISM INHIBITORS FOR THE TREATMENT OF DISEASE |
| DUAL MECHANISM INHIBITORS FOR THE TREATMENT OF DISEASE |